Large-scale electronics manufacturing and pharmaceuticals emerged as the biggest beneficiaries of India’s Production-Linked Incentive (PLI) schemes in 2024–25, cornering nearly 70% of the total fiscal disbursements. This reflects India’s sharpening focus on high-growth sectors to drive domestic manufacturing and exports.
PLI Disbursements Touch ₹10,114 Crore in FY25
According to official data, the government disbursed ₹10,114 crore under the PLI schemes during FY25. Of this, the electronics sector secured ₹5,732 crore, while pharmaceutical drugs accounted for ₹2,328 crore. This marks a modest rise from the previous year’s disbursals of ₹9,721 crore. Launched in 2021, the PLI scheme aims to bolster domestic production across 14 key sectors, with a total outlay of ₹1.97 lakh crore.
Sector-Wise Disbursals: Electronics and Pharma Lead
Beyond electronics and pharma, several other sectors received comparatively smaller incentive payouts in FY25:
- Telecom: ₹840 crore
- Food Processing: ₹448 crore
- White Goods: ₹210 crore
- Automobiles: ₹322 crore
- Medical Devices: ₹77 crore
- Specialty Steel: ₹48 crore
- Textiles: ₹40 crore
- Bulk Drugs: ₹22 crore
- Drones: ₹35 crore
The stark contrast underscores the strong traction and maturity achieved by the electronics and pharmaceutical sectors.
Electronics Sector: India’s Fastest-Growing Export Segment
PLI incentives have played a catalytic role in transforming India’s electronics sector into a global export powerhouse. Electronic goods exports witnessed a record growth of 32.46% in FY25, soaring to $38.58 billion, up from $29.12 billion in FY24. This trend follows previous leaps from $23.6 billion in FY23 and $15.7 billion in FY22. Among sub-categories, computer hardware and peripherals posted the most dramatic surge—doubling from $0.7 billion to $1.4 billion, representing 101% growth. Key export destinations for Indian electronics now include the UAE, the US, the Netherlands, the UK, and Italy, indicating a strong global footprint.
Pharmaceuticals: Expanding Global Reach
India’s pharmaceutical exports also maintained robust momentum, increasing by around 10% to reach $30.5 billion in FY25. Today, Indian drugs and pharmaceutical products are exported to over 200 countries, showcasing the sector’s reliability, scale, and regulatory compliance on a global stage.
Manufacturing Push Strengthens India’s Global Standing
As reported by outlookbusiness.com, the strong PLI disbursement trend highlights India’s strategic intent to strengthen its industrial base and become a reliable global supply partner. Electronics and pharma continue to thrive under the PLI umbrella. Other sectors may benefit from policy refinements and deeper investments in the years ahead.
